Select Publications

Book Chapters

McNeil HP; Krilis SA; Chesterman CN, 2020, 'Arterial Thrombosis—Diagnosis and Management', in Phospholipid-Binding Antibodies, CRC Press, pp. 191 - 203, http://dx.doi.org/10.1201/9780429278129-15

Qi M; Weaver JC; Rahgozar S; Giannakopoulos B; Krilis SA, 2019, 'Quantitation of total and free thiol angiotensinogen as a prognostic marker for preeclampsia', in Functional Disulphide Bonds : Methods and Protocols, pp. 285 - 293, http://dx.doi.org/10.1007/978-1-4939-9187-7_18

Qi M; Weaver JC; Krilis SA; Giannakopoulos B, 2019, 'Quantitation of total and free Thiol β2-Glycoprotein I levels for diagnostic and prognostic purposes in the antiphospholipid syndrome', in Functional Disulphide Bonds : Methods and Protocols, pp. 275 - 283, http://dx.doi.org/10.1007/978-1-4939-9187-7_17

Willis R; Cohen H; Giles I; Knight JS; Krilis SA; Rahman A; de Groot PG, 2017, 'Mechanisms of Antiphospholipid Antibody-Mediated Thrombosis', in Antiphospholipid Syndrome, Springer International Publishing, pp. 77 - 116, http://dx.doi.org/10.1007/978-3-319-55442-6_5

de Groot PG; de Laat B; Rand J; Vlachoyiannopoulos PG; El-Assaad F; Krilis SA; Giannakopoulos B, 2017, 'Natural Proteins Involved in Antiphospholipid Syndrome', in Antiphospholipid Syndrome, Springer International Publishing, pp. 15 - 27, http://dx.doi.org/10.1007/978-3-319-55442-6_2

Ioannou Y; Krilis SA, 2011, 'CHAPTER 52 Laboratory Testing for Antiphospholipid Syndrome', in Systemic Lupus Erythematosus, Elsevier, pp. 985 - 1000, http://dx.doi.org/10.1016/b978-0-12-374994-9.10052-x

Ioannou Y; Krilis SA, 2010, 'Laboratory Testing for Antiphospholipid Syndrome', in Systemic Lupus Erythematosus, Fifth Edition, pp. 985 - 1000, http://dx.doi.org/10.1016/B978-0-12-374994-9.10052-X

Giannakopoulos B; Yan XK; Krilis S, 2007, 'Antibodies and their antigenic targets in the antiphospholipid syndrome', in Murphy K; Ray M (ed.), A Companion to Rheumatology: Systemic Lupus Erythematosus, Mosby Elsevier, USA, pp. 233 - 240, http://dx.doi.org/10.1016/B978-0-323-04434-9.50028-2

Giannakopoulos B; Yan X; Krilis SA, 2007, 'Chapter 22B Antibodies and their Antigenic Targets in the Antiphospholipid Syndrome', in Systemic Lupus Erythematosus, Elsevier, pp. 233 - 240, http://dx.doi.org/10.1016/b978-0-323-04434-9.50028-2

Reddel SW; Krilis S, 2002, 'The Anti-Phospholipid Syndrome', in Theofilopoulos CA; Bona AN (ed.), The Molecular Pathology of Autoimmune Diseases, edn. Second, Taylor & Francis, USA, pp. 325 - 352

Reddel SW; Krilis S, 2001, 'Antiphospholipid syndrome', in Austen ; Frank ; Atkinson ; Cantor (ed.), Sampter`s Immunologic Diseases, edn. sixth, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 571 - 579

Li L; Reddel SW; Krilis S, 2000, 'Phenotypic similarities and differences between human basophils and mast cells', in Mast cells adn Basophils in Physiology, Pathology and Host Defence, edn. Original, Academic Press, San Diego, California

Li L; Reddel SW; Krilis SA, 2000, 'The Phenotypic Similarities and Differences Between Human Basophils and Mast Cells', in Mast Cells and Basophils, Elsevier, pp. 97 - 116, http://dx.doi.org/10.1016/b978-012473335-0/50009-x

Li L; Zhang X; Krilis S, 1999, 'Factors that affect humkan mast cell and basophil growth', in Signal transduction in mast cells and basophils, edn. Original, Springer Publishing Company, Berlin, pp. 54 - 65

Li Y; Li L; Krilis S, 1997, 'Growth factors modulating human mast cell growth and function', in Seminars in Clinical Immunology, edn. Original, Edizioni Grafiche Mazzucchelli S.B.L., Italy, pp. 17 - 24

Kandiah DA; Krilis S, 1996, 'Immunology and methods of detection of antiphospholipid antibodies', in The antiphospholipid syndrome, edn. Original, CRC Press, Boca Raton, pp. 29 - 48

Hunt J; Krilis , 1994, 'Immunology of Antiphospholipid Antibodies', in Panayi GS (ed.), Immunology of the Connective Tissue Diseases, Kluwer Academic Pub

Krilis S; Lewis RA; Corey EJ; Austen KF, 1983, 'Determinants for an Integrated Tissue Response to the Sulphidopeptide Leukotrienes', in Proceedings of Invited Symposia, Palgrave Macmillan UK, pp. 3 - 9, http://dx.doi.org/10.1007/978-1-349-17072-2_1

Journal articles

Zuo Y; Navaz S; Tsodikov A; Kmetova K; Kluge L; Ambati A; Hoy CK; Yalavarthi S; de Andrade D; Tektonidou MG; Sciascia S; Pengo V; Ruiz-Irastorza G; Belmont HM; Gerosa M; Fortin PR; de Jesus GR; Branch DW; Andreoli L; Rodriguez-Almaraz E; Petri M; Cervera R; Willis R; Karp DR; Li QZ; Cohen H; Bertolaccini ML; Erkan D; Knight JS; Pons-Estel G; Giannakopoulos B; Krilis S; de Jesus G; Levy R; Signorelli F; Andrade D; Balbi G; Clarke AE; Skeith L; Ji L; Zhang Z; Yang C; Shi H; Zuily S; Wahl D; Nalli C; Tincani A; Chighizola CB; Meroni P; Cheng C; Pazzola G; Foddai S; Radin M; Davis S; Amengual O; Atsumi T; Uthman I; Limper M; de Groot P; Ugarte A; Rodriguez-Pinto I; Ríos-Garcés R; Barilaro G; Pardos-Gea J; Almaraz ER; Cuadrado MJ; Zamorano MAA; Lopez-Pedrera C; Artim-Esen B; Inanc M; Cohen H; Efthymiou M; Khamashta M; Mackie I; Sanna G; Knight J; Zuo Y; Petri M; Leaf RK; Roubey R; Ortel T; Gonzalez E; Willis R; Kello N; Belmont M; Levine S; Rand J; Barbhaiya M; Salmon J; Lockshin M; Duarte Garcia AA, 2023, 'Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository', Arthritis and Rheumatology, 75, pp. 1407 - 1414, http://dx.doi.org/10.1002/art.42489

Chighizola CB; Pregnolato F; Andrade D; Tektonidou M; Pengo V; Ruiz-Irastorza G; Belmont HM; Gerosa M; Fortin P; Branch DW; Andreoli L; Petri MA; Cervera R; Knight JS; Willis R; Efthymiou M; Cohen H; Erkan D; Bertolaccini ML; Pons-Estel G; Giannakopoulos B; Krilis S; de Jesus G; Levy R; Signorelli F; Balbi G; Clarke AE; Skeith L; Fortin PR; Ji L; Zhang Z; Yang C; Shi H; Zuily S; Wahl D; Tektonidou MG; Nalli C; Tincani A; Chighizola CB; Meroni PL; Cheng C; Pazzola G; Sciascia S; Foddai S; Radin M; Davis S; Amengual O; Atsumi T; Uthman I; Limper M; de Groot P; Ugarte A; Rodriguez-Pinto I; Barilaro G; Ríos-Garcés R; Pardos-Gea J; Almaraz ER; Cuadrado MJ; Zamorano MAA; Lopez-Pedrera C; Artim-Esen B; Inanc M; Cohen H; Khamashta M; Mackie I; Sanna G; Knight J; Zuo Y; Petri M; Leaf RK; Roubey R; Ortel T; Gonzalez E; Willis R; Kello N; Belmont M; Levine S; Rand J; Barbhaiya M; Salmon J; Lockshin M; Duarte Garcia AA; Branch DW, 2023, 'Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies', Arthritis and Rheumatology, 75, pp. 984 - 995, http://dx.doi.org/10.1002/art.42459

Passam FH; Chen G; Chen VM; Qi M; Krilis SA; Giannakopoulos B, 2022, 'Βeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice', Journal of Autoimmunity, 126, http://dx.doi.org/10.1016/j.jaut.2021.102747

Barbhaiya M; Zuily S; Ahmadzadeh Y; Amigo MC; Avcin T; Bertolaccini M; Branch DW; de Jesus G; Devreese KMJ; Frances C; Garcia D; Guillemin F; Levine SR; Levy RA; Lockshin MD; Ortel T; Seshan SV; Tektonidou M; Wahl D; Willis R; Naden R; Costenbader K; Erkan D; Agmon-Levin N; Aguilar C; Alba P; Alpan O; Ambrozic A; Amoura Z; Andrade D; Andrade L; Appenzeller S; Esen BA; Atsumi T; Berkun Y; Cabral A; Canaud G; Cervera R; Chen P; Chighizola C; Cimaz R; Cohen H; Costedoat-Chalumeau N; Crowther M; Cuadrado MJ; de Groot PG; de Moerloose P; Derksen R; Diz-Kucukkaya R; Dörner T; Fortin P; Giannakopoulos B; Gómez-Puerta JA; Gonzalez EB; Inanc M; Kenet G; Khamashta M; Kriegel M; Krilis S; Laskin C; Massicotte P; McCarty G; Meroni PL; Mikdashi J; Myones B; Pengo V; Petri M; Roubey R; Sammaritano L; Sanna G; Sciascia S; Signorelli F; Soybilgic A; Tincani A; Woller S; Yelnik C, 2021, 'Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria', Arthritis Care and Research, 73, pp. 1490 - 1501, http://dx.doi.org/10.1002/acr.24520

Krilis M; Qi M; Ioannou Y; Zhang JY; Ahmadi Z; Wong JWH; Vlachoyiannopoulos PG; Moutsopoulos HM; Koike T; Sturgess AD; Chong BH; Krilis SA; Giannakopoulos B, 2021, 'Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk', Journal of Autoimmunity, 122, http://dx.doi.org/10.1016/j.jaut.2021.102675

Weaver JC; Ullah I; Qi M; Giannakopoulos B; Rye KA; Kockx M; Kritharides L; Krilis SA, 2020, 'Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease', Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 2794 - 2804, http://dx.doi.org/10.1161/ATVBAHA.120.315156

Zuily S; Clerc-Urmès I; Bauman C; Andrade D; Sciascia S; Pengo V; Tektonidou MG; Ugarte A; Gerosa M; Michael Belmont H; Zamorano MAA; Fortin P; Ji L; Efthymiou M; Cohen H; Branch DW; Jesus GRD; Nalli C; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Bertolaccini ML; Vega J; Wahl D; Erkan D; Pons-Estel G; Giannakopoulos B; Krilis S; de Jesus G; Levy R; Fortin PF; Zhang Z; Andreoli L; Tincani A; Chighizola CB; Meroni P; Banzato A; Davis S; Amengual O; Uthman I; Limper M; de Groot P; Irastorza GR; Rodríguez-Pintó I; Cuadrado MJ; Lopez-Pedrera R; Artim-Esen B; Inanc M; Khamashta M; Mackie I; Sanna G; Knight J; Roubey R; Ortel T; Gonzalez E; Belmont M; Levine S; Rand J; Barbhaiya M; Salmon J; Lockshin M, 2020, 'Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry', Lupus, 29, pp. 1353 - 1363, http://dx.doi.org/10.1177/0961203320940776

Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML, 2019, 'The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis', Thrombosis Research, 175, pp. 32 - 36, http://dx.doi.org/10.1016/j.thromres.2019.01.010

Krilis M; Qi M; Qi J; Wong JWH; Guymer R; Liew G; Hunyor AP; Madigan M; McCluskey P; Weaver J; Krilis SA; Giannakopoulos B, 2018, 'Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration', Free Radical Biology and Medicine, 129, pp. 237 - 246, http://dx.doi.org/10.1016/j.freeradbiomed.2018.09.034

Weaver JC; Krilis SA; Giannakopoulos B, 2018, 'Oxidative post-translational modification of βeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome', Free Radical Biology and Medicine, 125, pp. 98 - 103, http://dx.doi.org/10.1016/j.freeradbiomed.2018.03.048

El-Assaad F; Qi M; Gordon AK; Qi J; Dong S; Passam F; Weaver JC; Giannakopoulos B; Krilis SA, 2017, 'Βeta 2-glycoprotein i protects mice against gram-negative septicaemia in a sexually dimorphic manner', Scientific Reports, 7, http://dx.doi.org/10.1038/s41598-017-07945-8

Stevens RL; McNeil HP; Wensing LA; Shin K; Wong GW; Hansbro PM; Krilis SA, 2017, 'Experimental arthritis is dependent on mouse mast cell protease-5', Journal of Biological Chemistry, 292, pp. 5392 - 5404, http://dx.doi.org/10.1074/jbc.M116.773416

Krilis M; Qi M; Madigan MC; Wong JWH; Abdelatti M; Guymer RH; Whitelock J; McCluskey P; Zhang P; Qi J; Hunyor AP; Krilis SA; Giannakopoulos B, 2017, 'Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration', Oncotarget, 8, pp. 49016 - 49032, http://dx.doi.org/10.18632/oncotarget.14940

Dong S; Qi M; Wang Y; Chen L; Weaver JC; Krilis SA; Giannakopoulos B, 2017, 'β2GPI exerts an anti-obesity effect in female mice by inhibiting lipogenesis and promoting lipolysis', Oncotarget, 8, pp. 92652 - 92666, http://dx.doi.org/10.18632/oncotarget.21536

Ullah I; Qi M; Qi J; Giannakopoulos B; Weaver J; Krilis S, 2017, 'Development of Novel Assays for Quantitation of Total and Free Thiol Beta 2 Glycoprotein I', Heart, Lung and Circulation, 26, pp. S55 - S55, http://dx.doi.org/10.1016/j.hlc.2017.06.027

El-Assaad F; Krilis SA; Giannakopoulos B, 2016, 'Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome', Thrombosis Journal, 14, http://dx.doi.org/10.1186/s12959-016-0115-z

Zhou S; Chen G; Qi M; El-Assaad F; Wang Y; Dong S; Chen L; Yu D; Weaver JC; Beretov J; Krilis SA; Giannakopoulos B, 2016, 'Gram negative bacterial inflammation ameliorated by the plasma protein beta 2-Glycoprotein I', Scientific Reports, 6, http://dx.doi.org/10.1038/srep33656

Zhou S; Tanaka K; O'Keeffe M; Qi M; El-Assaad F; Weaver JC; Chen G; Weatherall C; Wang Y; Giannakopoulos B; Chen L; Yu DM; Hamilton MJ; Wensing LA; Stevens RL; Krilis SA, 2016, 'CD117+ dendritic and mast cells are dependent on RasGRP4 to function as accessory cells for optimal natural killer cell-mediated responses to lipopolysaccharide', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0151638

Zhang P; Weaver JC; Chen G; Beretov J; Atsumi T; Qi M; Bhindi R; Qi JC; Madigan MC; Giannakopoulos B; Krilis SA, 2016, 'The fifth domain of beta 2 glycoprotein I protects from natural IgM mediated cardiac ischaemia reperfusion injury', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0152681

Qi M; Abdelatti M; Krilis M; Madigan MC; Weaver J; Guymer RH; McCluskey P; Wang Y; Zhou S; Krilis SA; Giannakopoulos B, 2016, 'Do Beta 2-Glycoprotein i Disulfide Bonds Protect the Human Retina in the Setting of Age-Related Macular Degeneration?', Antioxidants and Redox Signaling, 24, pp. 32 - 38, http://dx.doi.org/10.1089/ars.2014.6052

Rahgozar S; Amirian T; Qi M; Shahshahan Z; Entezar-E-Ghaem M; Tehrani HG; Miroliaei M; Krilis SA; Giannakopoulos B, 2015, 'Improved assay for quantifying a redox form of angiotensinogen as a biomarker for pre-eclampsia: A case-control study', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0135905

Krilis SA; Giannakopoulos B, 2014, 'Laboratory methods to detect antiphospholipid antibodies', Hematology (United States), 2014, pp. 321 - 328, http://dx.doi.org/10.1182/asheducation-2014.1.321

Hansbro PM; Hamilton MJ; Fricker M; Gellatly SL; Jarnicki AG; Zheng D; Frei SM; Wong GW; Hamadi S; Zhou S; Foster PS; Krilis SA; Stevens RL, 2014, 'Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis', Journal of Biological Chemistry, 289, pp. 18214 - 18227, http://dx.doi.org/10.1074/jbc.M114.548594

Giannakopoulos B; Krilis S, 2014, 'In APS, two A1's are better than one!', Blood, 123, pp. 955 - 956, http://dx.doi.org/10.1182/blood-2013-12-542506

Giannakopoulos B; Mirarabshahi P; Qi M; Weatherall C; Qi JC; Tanaka K; Millar E; Vonthethoff L; Gatto D; Spielman D; Krilis SA, 2014, 'Deletion of the antiphospholipid syndrome autoantigen β2- glycoprotein i potentiates the lupus autoimmune phenotype in a toll-like receptor 7-mediated murine model', Arthritis and Rheumatology, 66, pp. 2270 - 2280, http://dx.doi.org/10.1002/art.38646

Douaiher J; Succar J; Lancerotto L; Gurish MF; Orgill DP; Hamilton MJ; Krilis SA; Stevens RL, 2014, 'Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing', , 122, pp. 211 - 252, http://dx.doi.org/10.1016/B978-0-12-800267-4.00006-7

Krilis M; Mao Q; Madigan M; Wong J; Abulatti M; Guymer R; McCluskey P; Zhang P; Qi J; Krilis S; Giannakopoulos B, 2013, 'POST TRANSLATIONALLY MODIFIED COMPLEMENT FACTOR H IN AGE RELATED MACULAR DEGENERATION', CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 41, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329507100022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yong A; Pennings G; Wong C; Javadzadegan A; Brieger D; Lowe H; Qi M; Behnia M; Krilis S; Kritharides L, 2013, 'Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease', International Journal of Cardiology, 166, pp. 716 - 721, http://dx.doi.org/10.1016/j.ijcard.2011.11.093

Giannakopoulos B; Krilis S, 2013, 'The Pathogenesis of the Antiphospholipid Syndrome', New England Journal of Medicine, 368, pp. 1033 - 1044

Giannakopoulos B; Gao L; Qi M; Wong JW; Yu D; Vlachoyiannopoulos P; Moutsopoulos HM; Atsumi T; Koike T; Hogg PJ; Qi JC; Krilis S, 2012, 'Factor XI is a substrate for oxidoreductases: Enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis.', Journal of Autoimmunity, 39, pp. 121 - 129, http://dx.doi.org/10.1016/j.jaut.2012.05.005

Mirarabshahii P; Abdelatti A; Krilis S, 2012, 'Post-translational oxidative modification of â2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.', Autoimmunity Reviews, 11, pp. 779 - 780, http://dx.doi.org/10.1016/j.autrev.2011.12.007

Adachi R; Krilis S; Nigrovic P; Hamilton MJ; Chung K; Thakurdas SM; Boyce JA; Anderson P; Stevens RL, 2012, 'Ras guanine nucleotide releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis.', The Journal of Biological Chemistry, 287, pp. 20047 - 20055, http://dx.doi.org/10.1074/jbc.M112.360388


Back to profile page